Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Custom Recombinant Proteins Market - Global Strategic Business Report 2026 | Capture the $10 Billion 2030 Shift as Thermo Fisher Scientific, Merck, GenScript, and Sino Biological Redefine Scale

globenewswire.com
TMO Thermo Fisher Scientific is mentioned as a leading participant in the custom recombinant proteins market, which is projected to grow significantly. The article does not provide specific sentiment towards the company's performance but lists it among key players. MRK Merck is listed as a key participant in the custom recombinant proteins market, which is experiencing growth. The article does not offer specific sentiment or performance details for Merck. BIO Bio-Rad Laboratories is identified as a participant in the custom recombinant proteins market. The article does not provide specific sentiment or performance details for the company. TECH Bio-Techne Corporation is mentioned as a participant in the custom recombinant proteins market. The article does not provide specific sentiment or performance details for the company.

Custom Recombinant Proteins Market - Global Strategic Business Report 2026 | Capture the $10 Billion 2030 Shift as Thermo Fisher Scientific, Merck, GenScript, and Sino Biological Redefine Scale Dublin, Oct. 05, 2026 (GLOBE NEWSWIRE) -- "Custom Recombinant Proteins Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

The global custom recombinant proteins market was valued at US$5.3 billion in 2024 and is projected to reach US$10 billion by 2030, expanding at a compound annual growth rate (CAGR) of 11.2%. Market growth is supported by rising biopharmaceutical research and development, expanding biologics pipelines, advances in protein engineering, and increasing adoption of precision medicine.

This comprehensive custom recombinant proteins market report examines industry trends, growth drivers, competitive dynamics, segment performance, and regional forecasts. It also incorporates recent global tariff developments, trade negotiations, supply chain disruption, sourcing changes, and geographic realignment affecting recombinant protein production and distribution.

Custom Recombinant Proteins Market Trends and Growth Drivers

Custom recombinant proteins have become critical components of biomedical research, therapeutic development, diagnostics, and biopharmaceutical manufacturing. Their specificity, consistency, and adaptability support protein-function studies, receptor-interaction analysis, enzyme research, antibody development, high-throughput screening, structural biology, diagnostic kit production, and vaccine formulation.

Demand is also increasing as biotherapeutic programs become more complex. Bispecific antibodies, fusion proteins, engineered enzymes, vaccines, and gene therapies frequently require proteins designed to meet precise structural and functional specifications. Growth in proteomics, biomarker discovery, immunotherapy, and personalized medicine is further increasing the need for customized protein constructs.

Technological innovation continues to improve protein design, expression, and purification. CRISPR and other genome-editing technologies support host-cell optimization, while advances in vectors, promoters, codon optimization, signal peptides, and folding chaperones improve yield, solubility, and functionality. Mammalian expression systems remain important for proteins requiring complex post-translational modifications, while bacterial, yeast, and insect systems provide additional production options.

Affinity chromatography, automated liquid handling, and high-resolution mass spectrometry are strengthening purity, reproducibility, and structural validation. Artificial intelligence-enabled protein design platforms are also helping researchers predict stability, activity, and immunogenicity before synthesis. End-to-end automation and cloud-based ordering platforms are shortening delivery timelines and broadening access to custom recombinant protein services.

Industry Demand and Application Outlook

Pharmaceutical and biotechnology companies are increasing their use of custom proteins in cell-based assays, toxicity testing, formulation development, target validation, and regulatory studies. Diagnostic developers require specialized biomarkers and detection targets for immunoassays and enzyme-linked immunosorbent assays. Academic and commercial research organizations are also expanding structural and functional proteomics programs involving engineered proteins, mutation panels, fluorescent tags, and site-specific modifications.

Additional opportunities are emerging in agricultural biotechnology, where custom proteins support plant-immunity research, disease-resistant crop development, and enzyme-based agricultural products. Contract research organizations are adopting recombinant protein services to accelerate project timelines and maintain experimental consistency.

Market Segment and Regional Insights

Report Scope

The report analyzes the custom recombinant proteins market by value in US dollars. Expression-system coverage includes mammalian, bacterial, insect, yeast, and other systems. End-user analysis encompasses research institutes, pharmaceutical and biotechnology companies, contract research organizations, and other users.

Geographic coverage includes the United States, Canada, Japan, China, Europe, Asia-Pacific, Latin America, the Middle East, and Africa, with country-level analysis for major national markets. Annual sales analysis and forecasts cover 2024 through 2030, supported by historical analysis from 2015 through 2023.

Domain Expert Insights

The report tracks changing market prospects, regional opportunities, technology developments, and competitive positioning across the custom recombinant proteins industry. Expert commentary from economists, trade specialists, and domain professionals assesses the effects of tariff negotiations involving more than 180 countries, economic uncertainty, supply chain turbulence, and structural changes in globalization.

Updated analysis includes revised global and regional forecasts through 2030, 2025 market share estimates, innovation trends, and the competitive positioning of leading participants. The report also identifies potential revenue opportunities arising from localized production, faster delivery models, biopharmaceutical expansion, and demand for difficult-to-express and multi-domain proteins.

Competitive Landscape

The report profiles 39 companies operating in the custom recombinant proteins market. Featured participants include Abcam plc, Abnova Corporation, ACROBiosystems, Aviva Systems Biology, Bio-Rad Laboratories, Bio-Techne Corporation, BPS Bioscience, Creative BioMart, GenScript Biotech Corporation, Merck KGaA, Miltenyi Biotec, Novoprotein Scientific, Proteintech Group, Sino Biological, and Thermo Fisher Scientific.

Key Report Benefits

Key Attributes

For more information about this report visit https://www.researchandmarkets.com/r/5gzik5

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.